Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 30;13(6):e234208.
doi: 10.1136/bcr-2019-234208.

Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations

Affiliations
Case Reports

Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations

Doaa Attia et al. BMJ Case Rep. .

Erratum in

Abstract

BCL6 corepressor like-1 (BCORL1) mutation has rarely been described in thyroid cancer or in association with BRAF mutations in any malignancy. However, we report a 49-year-old woman who had aggressive follicular variant papillary thyroid carcinoma (FV-PTC) with both the BRAF K601E and BCORL1 mutations. The patient underwent a total thyroidectomy for a 3.6 cm right thyroid nodule and a smaller lesion in the left lobe in 2007; both were FV-PTCs with no lymphovascular invasion or metastases. In 2015, a positron emission tomography-CT scan showed a small defect in the left posterior lateral fifth rib with mild increased hypermetabolic activity with standardised uptake value of 3.9 and another lesion in the right hip at the junction of the femoral neck and trochanter. Tumour biopsy and genetic analysis revealed an uncommon BRAF K601E and a rare BCORL1 mutation. While rare, we report a case of aggressive FV-PTC with both the BRAF K601E and BCORL1 mutations.

Keywords: endocrine cancer; head and neck cancer; thyroid disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Primary thyroid tumour showing follicular growth pattern, 20× magnification.
Figure 2
Figure 2
Primary tumour showing more solid growth pattern as well as more obvious papillary thyroid cancer features, 40× magnification.
Figure 3
Figure 3
Positron emission tomography–CT scan of rib metastasis of follicular variant papillary thyroid carcinoma.
Figure 4
Figure 4
Rib metastasis, with follicles and colloid, 10× magnification.
Figure 5
Figure 5
FDG–positron emission tomography/CT scan showing subtle uptake in right femoral neck metastasis.
Figure 6
Figure 6
Timeline of patient’s clinical course.

Similar articles

References

    1. Torregrossa L, Viola D, Sensi E, et al. . Papillary thyroid carcinoma with rare exon 15 BRAF mutation has indolent behavior: a single-institution experience. J Clin Endocrinol Metab 2016;101:4413–20. 10.1210/jc.2016-1775 - DOI - PubMed
    1. Afkhami M, Karunamurthy A, Chiosea S, et al. . Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation. Thyroid 2016;26:242–7. 10.1089/thy.2015.0227 - DOI - PubMed
    1. Cancer Genome Atlas Research Network Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159:676–90. 10.1016/j.cell.2014.09.050 - DOI - PMC - PubMed
    1. Trovisco V, Vieira de Castro I, Soares P, et al. . Braf mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 2004;202:247–51. 10.1002/path.1511 - DOI - PubMed
    1. Pennelli G, Vianello F, Barollo S, et al. . BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid 2011;21:1393–6. 10.1089/thy.2011.0120 - DOI - PubMed

Publication types

MeSH terms